These histopathological changes, which we utilized as indicators to evaluate the effect of α-synuclein PFF injection, partially replicated the pathologic changes observed in SNCA transgenic mice [37] and in patients with PD [27], indicating the relevance of our model in evaluating PD pathology. This evidence concerns the gene SNCA and Parkinson disease.